11 Sep, 2013
12:30pm – 1:30pm
Room A824, 8/F, Cheng Yu Tung Tower, Centennial Campus, The University of Hong Kong
Dr. Brian Sloan,College Lecturer in Law, Robinson College, University of Cambridge, London
Every day, large numbers of altruistic individuals, in the absence of any legal duty, provide substantial and essential services for elderly and disabled people. In doing so, many such informal carers suffer financial and other disadvantages. Drawing on his recent book, Informal Carers and Private Law, Dr Sloan will consider the scope for a “private law” approach to rewarding, supporting or compensating carers, an increasingly vital topic in the context of an ageing population and the perceived need for savings in public expenditure. Adopting a comparative approach covering England and Wales and several other common law jurisdictions, Dr Sloan will explore the recognition of the informal carer and his or her relationship with the care recipient within diverse fields of private law, from unjust enrichment to succession. In considering the potential for expansion of a “private law” approach for carers, he will address the fundamental and controversial question of the price of altruism.
“Brian Sloan read for his BA in Law and LLM degree at Robinson College, Cambridge. He then undertook doctoral studies in family and property law at Gonville and Caius College, Cambridge under the supervision of Professor Kevin Gray and Dr Jens M Scherpe. His PhD was conferred in 2011. Between 2009 and 2012, Brian was Bob Alexander Fellow at King’s College, Cambridge. In October 2012 he returned to Robinson as College Lecturer, Director of Studies and Fellow in Law, where he teaches Equity, Family Law and Land Law. His research interests include informal carers in comparative private law, the regulation of adult relationships, the application of property law in the domestic sphere and the law of adoption.”
6 Sep, 2013 - 7 Sep, 2013
Large Moot Court Room, 2/F, Cheng Yu Tung Tower, Centennial Campus, The University of Hong Kong
Reform of the regulation of medical practitioners in Hong Kong: a comparison with the UK and Singapore, and the results of a public survey
13 Jun, 2013
12:30pm – 1:30pm
Room 403, 4/F, Professorial Block, Queen Mary Hospital, Pok Fu Lam Road, Hong Kong
Dr TK Chan, MBCHB(CUHK), MRCS (England, Edinburgh), LLM(Edinburgh)
A recent incident in which a lady died from a blood transfusion therapy given in a beauty centre has prompted us to reflect on the current regulation of medical practitioners in Hong Kong. Based on a comparison with the current regulation in the United Kingdom and Singapore (both of which have a similar healthcare system to ours), we propose reform in Hong Kong in respect of the constitution of regulators, revalidation of medical professionals, and tackling concerns about medical professionals. We conduct a cross-sectional telephone survey amongst members of the general public of Hong Kong to collect their opinion on our proposed reform. As expected, the majority of the respondents supported all our proposed changes. Accordingly, we strongly call for a change with a view to strengthening the current regulatory framework in order to restore confidence from the public.
Dr Chan graduated from the Chinese University of Hong Kong in 2005 and qualified as a medical practitioner in Hong Kong in 2006. He completed his basic surgical training and obtained his membership from the Royal Colleges of Surgeons of England and Edinburgh in 2009 and 2010 respectively. His fascination with surgical anatomy brought him to the department of anatomy as a teacher and his interest in medical law and ethics saw him complete the masters of law degree from the University of Edinburgh in 2012. He is keen on critically reviewing current law and ethics from the perspectives of patients.
30 May, 2013
12:30pm – 1:30pm
Room A825, 8/F, Cheng Yu Tung Tower, Centennial Campus, The University of Hong Kong
Dr. Chih-hsing Ho, Centre for Medical Ethics and Law, The University of Hong Kong
Biobanks collect biological samples and associated data for medical research and diagnostic purposes. As contemporary medicine is moving from reactive approaches to predictive, preventive, personalised and participatory medicine (P4 Medicine), biobanks have become powerful tools with the potential to drive this transition in drug innovation and health care delivery. However, the practice of biobanking also raises considerable challenges for existing legal principles and regulatory frameworks. This talk explores these challenges and possible solutions to achieve appropriate governance structures for biobanking in the future.